Skip to main content

Table 2 Cost-effectiveness ratios for intermediate degrees of vaccine efficacy in preventing cases of NBPD in 5 European countries.

From: Policymaking based on CERs: changes in costs are not the same as changes in benefits

Assumed preventive Power against NBPD Belgium France Scotland Spain Sweden
0% effectiveness against NBPD 25907 19182 14892 10511 32675
Step 1 (10% increase) 13678 15801 6858 4383 10158
Step 2 (20% increase) 8313 13085 4167 2126 4217
Step 3 (30% increase) 5300 10857 2820 954 1473
Step 4 (40% increase) 3370 8995 2010 235 Cost saving
Step 5 (50% increase) 2028 7415 1470 Cost saving Cost saving
Step 6 (60% increase) 1041 6058 1084 Cost saving Cost saving
Step 7 (70% increase) 285 4881 795 Cost saving Cost saving
Step 8 (80% increase) Cost saving 3849 570 Cost saving Cost saving
Step 9 (90% increase) Cost saving 2938 390 Cost saving Cost saving
Step 10 (same effectiveness against NBPD as against BPD) Cost saving 2127 242 Cost saving Cost saving